The role of estrogens for male bone health.
暂无分享,去创建一个
[1] A. Meikle. Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men , 2010 .
[2] B. Olde,et al. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[3] B. Olde,et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. , 2009, Endocrinology.
[4] A. Silman,et al. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. , 2009, The Journal of clinical endocrinology and metabolism.
[5] D. Mellström,et al. Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] E. Ghigo,et al. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. , 2008, Bone.
[7] T. Travison,et al. Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. , 2008, The Journal of clinical endocrinology and metabolism.
[8] Tudor I. Oprea,et al. GPR30: a novel therapeutic target in estrogen-related disease. , 2008, Trends in pharmacological sciences.
[9] Tudor I. Oprea,et al. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. , 2008, Annual review of physiology.
[10] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[11] J. Eisman,et al. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. , 2008, Archives of internal medicine.
[12] A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study. , 2007, European journal of endocrinology.
[13] D. Kiel,et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. , 2006, The American journal of medicine.
[14] O. Johnell,et al. Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] S. Boonen,et al. Relative Impact of Androgen and Estrogen Receptor Activation in the Effects of Androgens on Trabecular and Cortical Bone in Growing Male Mice: A Study in the Androgen Receptor Knockout Mouse Model , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] S. Andò,et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.
[17] D. Mellström,et al. Polymorphisms in the Aromatase Gene Predict Areal BMD as a Result of Affected Cortical Bone Size: The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] S. Andò,et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.
[19] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[20] Eric R. Prossnitz,et al. A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.
[21] J. Dong,et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. , 2005, Endocrinology.
[22] A. Hofman,et al. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. , 2004, The Journal of clinical endocrinology and metabolism.
[23] M. Brandi,et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. , 2004, The Journal of clinical endocrinology and metabolism.
[24] E. Simpson,et al. Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose , 2003, Breast Cancer Research and Treatment.
[25] R. Nuti,et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. , 2003, The Journal of clinical endocrinology and metabolism.
[26] J. Gustafsson,et al. Differential effects on bone of estrogen receptor α and androgen receptor activation in orchidectomized adult male mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Kaufman,et al. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. , 2003, The Journal of clinical endocrinology and metabolism.
[28] R. Baron,et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. , 2003, The Journal of clinical investigation.
[29] K. Dahlman-Wright,et al. Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .
[30] K. Dahlman-Wright,et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. , 2003, Molecular endocrinology.
[31] K. Sjögren,et al. Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] D. Leroith,et al. Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.
[33] K. Dahlman-Wright,et al. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.
[34] Sundeep Khosla,et al. Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.
[35] B. Riggs,et al. Estrogen and the Male Skeleton , 2002 .
[36] S. Mohan,et al. Two Different Pathways for the Maintenance of Trabecular Bone in Adult Male Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] R. Baron,et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. , 2002, Bone.
[38] K. Bland,et al. Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis , 2001 .
[39] J. Gustafsson,et al. Estrogen receptor specificity in the regulation of the skeleton in female mice. , 2001, The Journal of endocrinology.
[40] L. Melton,et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. , 2001, The Journal of clinical endocrinology and metabolism.
[41] S. Windahl,et al. Female Estrogen Receptor β−/− Mice Are Partially Protected Against Age‐Related Trabecular Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[42] J. Clive,et al. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. , 2001, The Journal of clinical endocrinology and metabolism.
[43] S. Boonen,et al. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. , 2000, Biochemical and biophysical research communications.
[44] P. Delmas,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study* , 2022 .
[45] D. Kiel,et al. Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study , 2000, Annals of Internal Medicine.
[46] D. Grobbee,et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.
[47] J. Gustafsson,et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] V. Rochira,et al. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. , 2000, The Journal of clinical endocrinology and metabolism.
[49] D. Mühlen,et al. Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. , 2000, The Journal of clinical endocrinology and metabolism.
[50] J. Eisman,et al. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. , 1999, The Journal of clinical endocrinology and metabolism.
[51] J. Gustafsson,et al. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.
[52] D. Leroith,et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Sjögren,et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] C. Ohlsson,et al. Expression and Localization of Estrogen Receptor‐β in Murine and Human Bone , 1999 .
[55] C. Ohlsson,et al. Expression and localization of estrogen receptor-beta in murine and human bone. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[56] C. Ohlsson,et al. Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. , 1999, The Journal of clinical endocrinology and metabolism.
[57] S. Chanprasertyothin,et al. Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males , 1998, Clinical endocrinology.
[58] Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.
[59] G G Klee,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .
[60] E. Barrett-Connor,et al. Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[61] C. Slemenda,et al. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. , 1997, The Journal of clinical investigation.
[62] K. Korach,et al. Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.
[63] S. Boonen,et al. Androgens and bone. , 2004, Calcified tissue international.
[64] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[65] K. Korach,et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.